The Europe Vaccines Market is expected to reach US$ 16,291.0 Mn in 2027 from US$ 9,576.2 Mn in 2018. The market is estimated to grow with a CAGR of 5.5% from 2019-2027.

Europe Vaccines Market Introduction

The European vaccines market is currently on an upward trajectory, significantly bolstered by escalating public awareness programs regarding vaccination and a surge in vaccines research and development activities across the continent. However, the persistent challenge of vaccine hesitancy within the European region is anticipated to temper the overall market growth during the forecast period.

Vaccination is a critical tool for public health, demonstrably saving lives and profoundly enhancing the quality of life. For instance, Polio, an infectious disease caused by poliovirus, leads to debilitating muscle weakness and a loss of mobility. The polio vaccine offers robust protection by inducing the production of antibodies in the bloodstream. Thanks to the vigorous promotion of the polio vaccine in Europe, the World Health Organization declared the European Region polio-free in 2002, a testament to the power of widespread immunization.

Countries throughout the European region are actively collaborating to eradicate infectious diseases like measles, diphtheria, rubella, and pertussis through comprehensive vaccination programs. To achieve this, numerous vaccination programs, impactful campaigns, and educational conferences are regularly held to raise public awareness. European Immunization Week (EIW), celebrated annually in April, underscores the vital importance of vaccination for health and well-being. The European Centre for Disease Prevention and Control (ECDC) supports the WHO/Europe EIW campaign by providing crucial scientific evidence on vaccination.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/TIPRE00005750

Europe Vaccines Strategic Insights

Strategic insights for the Europe Vaccines market provide a data-driven analysis of the industry, encompassing current trends, key players, and regional specifics. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped market segments or developing unique value propositions. By leveraging data analytics, these insights help industry players anticipate market shifts. A future-oriented perspective is essential, helping stakeholders foresee market changes and strategically position themselves for long-term success within this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

EUROPE VACCINES MARKET – SEGMENTATION

Europe Vaccines Market – By Technology

• Recombinant vaccines
• Conjugate Vaccines
• Live Attenuated Vaccines
• Inactivated Vaccines
• Toxoid Vaccines

EUROPE VACCINES MARKET – By Disease Indication

• DTP (diphtheria, tetanus, and pertussis)
• Influenza
• Hepatitis
• Other Diseases

EUROPE VACCINES MARKET – By Rout of Administration

• Oral
• Injectable
• Other

EUROPE VACCINES MARKET – By Patient Type

• Adults
• Pediatric

EUROPE VACCINES MARKET – By Country

• Germany
• France
• UK
• Italy
• Spain       

 EUROPE VACCINES MARKET – Companies Mentioned

• PFIZER INC
• GlaxoSmithKline plc.
• Merck & Co., Inc.
• Sanofi
• Johnson & Johnson Services, Inc
• Panacea Biotec Limited
• Astellas Pharma Inc.
• NOVAVAX, INC.
• VBI Vaccines Inc
• Bavarian Nordic

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications